- Release Date: 07/02/13 11:23
- Summary: Acquisition of Enigma Therapeutics Presentation
- Price Sensitive: No
- Download Document 898.56KB
- Forums
- ASX - By Stock
- NDL
- Ann: Acquisition of Enigma Therapeutics Presentat
Ann: Acquisition of Enigma Therapeutics Presentat
Featured News
Add NDL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online